Community-acquired methicillin-resistant Staphylococcus aureus: not just a spider bite.
Methicillin-resistant Staphylococcus aureus has been commonly known to be found in hospital or healthcare settings; however, increased prevalence within the community has posed a concern to providers with treatment management and costs. Community-acquired methicillin-resistant Staphylococcus aureus infections typically present as skin and soft tissue infections but do not respond to typical skin and soft tissue infection treatment. Methicillin-resistant Staphylococcus aureus can also lead to more serious systemic infections, even in the healthy individual. With this, the healthcare provider must be aware of the prevalence and populations with increased risk and the recommended treatment and education. Assessment, diagnosis, education, and treatments must be appropriate and meet the needs of the individual. Therefore, this article provides current assessment and treatment recommendations through a typical case study.
Vozdecky
Charolette
C
University South Florida, College of Nursing, Graduate Studies, Tampa, Fla. 33612, USA. cvozdecky@tampabay.rr.com
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002506:Cephalexin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D003646:Debridement; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D010353:Patient Education as Topic; D015995:Prevalence; D012307:Risk Factors; D001098:Spider Bites / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D013207:Staphylococcal Skin Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002506:Cephalexin